Case number 1:20-cv-00201
Amgen Inc. et al v. Hospira, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 21, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [100] Stipulation of Dismissal, filed by Amgen Inc., Amgen Manufacturing, Limited. CASE CLOSED. Ordered by Judge Colm F. Connolly on 3/21/2022. (kmd) |
| Mar 21, 2022 | 101 | Patent/Trademark Report to Commissioner (Main Document) (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,273,707. (Attachments: # (1) Stipulation and Order of Dismissal with Prejudice)(kmd) (Main Document 101 replaced on 3/21/2022) (kmd). |
| Mar 21, 2022 | 101 | Patent/Trademark Report to Commissioner (Stipulation and Order of Dismissal with Prejudice) (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,273,707. (Attachments: # (1) Stipulation and Order of Dismissal with Prejudice)(kmd) (Main Document 101 replaced on 3/21/2022) (kmd). |
| Mar 18, 2022 | 100 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal With Prejudice by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine) |
| Oct 25, 2021 | 97 | Redacted Document (Main Document) (6) Docket Text: REDACTED VERSION of [95] Statement, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Index, # (2) Exhibit Tab 1, # (3) Exhibit Tab 2, # (4) Certificate of Service)(Gattuso, Dominick) |
| Oct 25, 2021 | 97 | Redacted Document (Index) (1) Docket Text: REDACTED VERSION of [95] Statement, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Index, # (2) Exhibit Tab 1, # (3) Exhibit Tab 2, # (4) Certificate of Service)(Gattuso, Dominick) |
| Oct 25, 2021 | 97 | Redacted Document (Exhibit Tab 1) (15) Docket Text: REDACTED VERSION of [95] Statement, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Index, # (2) Exhibit Tab 1, # (3) Exhibit Tab 2, # (4) Certificate of Service)(Gattuso, Dominick) |
| Oct 25, 2021 | 97 | Redacted Document (Exhibit Tab 2) (30) Docket Text: REDACTED VERSION of [95] Statement, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Index, # (2) Exhibit Tab 1, # (3) Exhibit Tab 2, # (4) Certificate of Service)(Gattuso, Dominick) |
| Oct 25, 2021 | 97 | Redacted Document (Certificate of Service) (1) Docket Text: REDACTED VERSION of [95] Statement, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Index, # (2) Exhibit Tab 1, # (3) Exhibit Tab 2, # (4) Certificate of Service)(Gattuso, Dominick) |
| Oct 25, 2021 | 98 | Redacted Document (Main Document) (26) Docket Text: REDACTED VERSION of [96] Reply Brief, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Certificate of Service)(Gattuso, Dominick) |
| Oct 25, 2021 | 98 | Redacted Document (Certificate of Service) (1) Docket Text: REDACTED VERSION of [96] Reply Brief, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Certificate of Service)(Gattuso, Dominick) |
| Oct 25, 2021 | 99 | Request for Oral Argument (2) Docket Text: REQUEST for Oral Argument by Amgen Inc., Amgen Manufacturing, Limited re [79] MOTION for Summary Judgment of Noninfringement of the Asserted Claims of U.S. Patent No. 8,273,707. (Cragg, Tyler) |
| Sep 10, 2021 | 90 | Redacted Document (30) Docket Text: REDACTED VERSION of [85] Declaration by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine) |
| Sep 10, 2021 | 91 | Redacted Document (30) Docket Text: REDACTED VERSION of [86] Answering Brief in Opposition, by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine) |
| Sep 10, 2021 | 92 | Redacted Document (14) Docket Text: REDACTED VERSION of [87] Statement by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine) |
| Sep 10, 2021 | 93 | Redacted Document (30) Docket Text: REDACTED VERSION of [88] Declaration by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine) |
| Sep 10, 2021 | 94 | Redacted Document (30) Docket Text: REDACTED VERSION of [89] Declaration by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine) |
| Aug 20, 2021 | 83 | Redacted Document (Main Document) (10) Docket Text: REDACTED VERSION of [80] Statement, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Index, # (2) Exhibit Tab 1, # (3) Exhibit Tab 2, # (4) Exhibit Tab 3, # (5) Exhibit Tabs 4-5 (Remain Under Seal), # (6) Exhibit 6, # (7) Certificate of Service)(Gattuso, Dominick) |
| Aug 20, 2021 | 83 | Redacted Document (Index) (1) Docket Text: REDACTED VERSION of [80] Statement, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Index, # (2) Exhibit Tab 1, # (3) Exhibit Tab 2, # (4) Exhibit Tab 3, # (5) Exhibit Tabs 4-5 (Remain Under Seal), # (6) Exhibit 6, # (7) Certificate of Service)(Gattuso, Dominick) |
| Aug 20, 2021 | 83 | Redacted Document (Exhibit Tab 1) (15) Docket Text: REDACTED VERSION of [80] Statement, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Index, # (2) Exhibit Tab 1, # (3) Exhibit Tab 2, # (4) Exhibit Tab 3, # (5) Exhibit Tabs 4-5 (Remain Under Seal), # (6) Exhibit 6, # (7) Certificate of Service)(Gattuso, Dominick) |
| Aug 20, 2021 | 83 | Redacted Document (Exhibit Tab 2) (30) Docket Text: REDACTED VERSION of [80] Statement, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Index, # (2) Exhibit Tab 1, # (3) Exhibit Tab 2, # (4) Exhibit Tab 3, # (5) Exhibit Tabs 4-5 (Remain Under Seal), # (6) Exhibit 6, # (7) Certificate of Service)(Gattuso, Dominick) |
| Aug 20, 2021 | 83 | Redacted Document (Exhibit Tab 3) (15) Docket Text: REDACTED VERSION of [80] Statement, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Index, # (2) Exhibit Tab 1, # (3) Exhibit Tab 2, # (4) Exhibit Tab 3, # (5) Exhibit Tabs 4-5 (Remain Under Seal), # (6) Exhibit 6, # (7) Certificate of Service)(Gattuso, Dominick) |
| Aug 20, 2021 | 83 | Redacted Document (Exhibit Tabs 4-5 (Remain Under Seal)) (1) Docket Text: REDACTED VERSION of [80] Statement, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Index, # (2) Exhibit Tab 1, # (3) Exhibit Tab 2, # (4) Exhibit Tab 3, # (5) Exhibit Tabs 4-5 (Remain Under Seal), # (6) Exhibit 6, # (7) Certificate of Service)(Gattuso, Dominick) |
| Aug 20, 2021 | 83 | Redacted Document (Exhibit 6) (3) Docket Text: REDACTED VERSION of [80] Statement, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Index, # (2) Exhibit Tab 1, # (3) Exhibit Tab 2, # (4) Exhibit Tab 3, # (5) Exhibit Tabs 4-5 (Remain Under Seal), # (6) Exhibit 6, # (7) Certificate of Service)(Gattuso, Dominick) |
| Aug 20, 2021 | 83 | Redacted Document (Certificate of Service) (1) Docket Text: REDACTED VERSION of [80] Statement, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Index, # (2) Exhibit Tab 1, # (3) Exhibit Tab 2, # (4) Exhibit Tab 3, # (5) Exhibit Tabs 4-5 (Remain Under Seal), # (6) Exhibit 6, # (7) Certificate of Service)(Gattuso, Dominick) |
| Aug 20, 2021 | 84 | Redacted Document (Main Document) (26) Docket Text: REDACTED VERSION of [81] Opening Brief in Support, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Certificate of Service)(Gattuso, Dominick) |
| Aug 20, 2021 | 84 | Redacted Document (Certificate of Service) (1) Docket Text: REDACTED VERSION of [81] Opening Brief in Support, by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Certificate of Service)(Gattuso, Dominick) |
| Aug 17, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [82] STIPULATION TO EXTEND TIME Redactions to August 20, 2021 filed by Hospira, Inc., Pfizer Inc. Signed by Judge Colm F. Connolly on 8/17/2021. (fms) |
| Aug 13, 2021 | 82 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME Redactions to August 20, 2021 - filed by Hospira, Inc., Pfizer Inc.. (Gattuso, Dominick) |
| Aug 6, 2021 | 79 | Motion for Summary Judgment (Main Document) (2) Docket Text: MOTION for Summary Judgment of Noninfringement of the Asserted Claims of U.S. Patent No. 8,273,707 - filed by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Text of Proposed Order [Proposed] Order)(Gattuso, Dominick) |
| Aug 6, 2021 | 79 | Motion for Summary Judgment (Text of Proposed Order [Proposed] Order) (1) Docket Text: MOTION for Summary Judgment of Noninfringement of the Asserted Claims of U.S. Patent No. 8,273,707 - filed by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Text of Proposed Order [Proposed] Order)(Gattuso, Dominick) |
| Jul 30, 2021 | 78 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Dominick T. Gattuso, Esquire regarding Response to Plaintiffs' July 16, 2021 letter - re [76] Order,, Set Deadlines,, Order Lifting Stay, [77] Letter. (Gattuso, Dominick) |
| Jul 16, 2021 | 77 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Plaintiffs Request for Clarification of Court Order - re [76] Order,, Set Deadlines,, Order Lifting Stay,. (Whetzel, Robert) |
| Jul 14, 2021 | 76 | Order (5) Docket Text: ORDER regarding briefing for summary judgment on the issue of noninfringement. ORDER, Setting Deadlines: ( Dispositive Motion, Opening Brief and Concise Statement of Facts due by 8/6/2021., Answering Brief and Concise Statement of Facts due by 9/3/2021., Reply Brief due 10/18/2021.) Signed by Judge Colm F. Connolly on 7/14/2021. (nmf) |
| Jul 12, 2021 | 75 | Letter (7) Docket Text: Letter to Honorable Colm F. Connolly from Robert W. Whetzel regarding Joint Status Update on Summary Judgment Practice - re Markman Hearing. (Whetzel, Robert) |
| Jun 16, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: For the reasons set forth at June 11, 2021 hearing, it is hereby ORDERED that the case is STAYED until a determination is made about whether the Court should entertain summary judgment practice on the issue of noninfringement. It is further ORDERED that the parties shall jointly submit a status update by July 12, 2021. Ordered by Judge Colm F. Connolly on 6/16/2021. (nmf) |
| Jun 16, 2021 | 74 | Order (2) Docket Text: ORDER: IT IS HEREBY ORDERED that the claim term "between about 0.1 M and about 1.0" is construed to have its plain and ordinary meaning (that is, "between approximately 0.1 M and approximately 1.0 M") and is not a functional limitation. Signed by Judge Colm F. Connolly on 6/16/2021. (nmf) |
| Jun 11, 2021 | N/A | Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Markman Hearing held on 6/11/2021. (Court Reporter V. Gunning.) Counsel to file their joint submission on or before July 12, 2021. (nmf) |
| Apr 13, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER re [73] Letter, ORDER, Setting Hearings: The Markman Hearing is rescheduled for 6/11/2021 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Ordered by Judge Colm F. Connolly on 4/13/2021. (nmf) |
| Apr 9, 2021 | 73 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding Proposed Dates for Markman. (Whetzel, Robert) |
| Apr 8, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court has read Plaintiffs' April 7 letter (D.I. [72]). The Court understood Mr. Groombridge's response to be in substance what Plaintiffs outline in their letter. The Court asked an imprecise question. But the Court had in mind what Mr. Groombridge had in mind. Mr. Groombridge has appeared before the Court on numerous occasions and the Court appreciates and respects his practice of conceding points he should concede and getting to the heart of the disputed matters before the Court. All counsel would do well to follow his lead in that regard. Ordered by Judge Colm F. Connolly on 4/8/2021. (nmf) |
| Apr 7, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Rebecca E. Fett for Amgen Inc. and Amgen Manufacturing, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Apr 7, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Rebecca E. Fett for Amgen Inc., for Amgen Manufacturing, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Apr 7, 2021 | 72 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding the April 6, 2021 teleconference - re Oral Order,, Order Staying Case,. (Whetzel, Robert) |
| Apr 6, 2021 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 4/6/2021. (Court Reporter V. Gunning.) (nmf) |
| Apr 6, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [69] MOTION for Pro Hac Vice Appearance of Attorney Rebecca Fett filed by Amgen Inc., Amgen Manufacturing, Limited. Signed by Judge Colm F. Connolly on 4/6/2021. (nmf) |
| Apr 6, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER STAYING CASE: The case is stayed pending the Court's construction of the "between about 0.1 M and about 1.0" limitation. The parties shall inform the Court by April 9, 2021 whether the hearing scheduled for April 26 will go forward on that date or should be moved to another date. Ordered by Judge Colm F. Connolly on 4/6/2021. (nmf) |
| Apr 6, 2021 | 70 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Jacob T. Whitt as co-counsel.. (Mowery, Katharine) |
| Apr 6, 2021 | 71 | Answer to Complaint (27) Docket Text: ANSWER to [1] Complaint, with Jury Demand , COUNTERCLAIM against All Plaintiffs by Pfizer Inc., Hospira, Inc..(Gattuso, Dominick) |
| Apr 5, 2021 | 69 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Rebecca Fett - filed by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine) |
| Mar 31, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER re [68] Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding claim construction, ORDER Setting Teleconference: Counsel for Plaintiffs to coordinate the call and email the dial-in information to chambers. A Telephone Conference is set for 4/6/2021 at 01:00 PM before Judge Colm F. Connolly. Ordered by Judge Colm F. Connolly on 3/31/2021. (nmf) |
| Mar 30, 2021 | 68 | Letter (4) Docket Text: Letter to The Honorable Colm F. Connolly from Robert W. Whetzel regarding claim construction. (Whetzel, Robert) |
| Mar 26, 2021 | 66 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Dominick T. Gattuso, Esquire regarding Claim Construction. (Gattuso, Dominick) |
| Mar 26, 2021 | 67 | Claim Construction Chart (Main Document) (2) Docket Text: CLAIM Construction Chart by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Mowery, Katharine) |
| Mar 26, 2021 | 67 | Claim Construction Chart (Exhibit 1) (6) Docket Text: CLAIM Construction Chart by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Mowery, Katharine) |
| Mar 26, 2021 | 67 | Claim Construction Chart (Exhibit 2) (15) Docket Text: CLAIM Construction Chart by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Mowery, Katharine) |
| Mar 23, 2021 | N/A | Oral Argument (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Oral Argument held on 3/23/2021. (Court Reporter V. Gunning.) (nmf) |
| Mar 23, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: For the reasons stated by the Court during today's telephonic argument, Defendants' motion to dismiss (D.I. [12]) is DENIED. Ordered by Judge Colm F. Connolly on 3/23/2021. (nmf) |
| Mar 19, 2021 | N/A | Remark (0) Docket Text: Remark: Having received a request from a member of the public to listen to the oral argument set for 3/23/2021 at 10:00 a.m., the call information is: US: +1 267 831 0333 Meeting ID: 893 3596 5550 Passcode: 80236072 (fms) |
| Mar 19, 2021 | N/A | Remark (0) Docket Text: Remark: The call information for the 3/23/2021 telephonic oral argument has changed. The new call information is: US : +1 301 715 8592 or +1 312 626 6799 Meeting ID: 892 4284 1319 Passcode: 69641359 (fms) |
| Mar 19, 2021 | 64 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Elizabeth A. DeFelice on behalf of Hospira, Inc., Pfizer Inc. (DeFelice, Elizabeth) |
| Mar 19, 2021 | 65 | Letter (1) Docket Text: Letter to the Honorable Colm F. Connolly from Robert W. Whetzel regarding a disputed issue raised by Defendants - re [12] MOTION to Dismiss for Failure to State a Claim . (Whetzel, Robert) |
| Mar 15, 2021 | 62 | Joint Claim Construction Brief (30) Docket Text: JOINT CLAIM CONSTRUCTION BRIEF filed by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine) |
| Mar 15, 2021 | 63 | Appendix (Main Document) (3) Docket Text: APPENDIX re [62] Joint Claim Construction Brief by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-5B)(Mowery, Katharine) |
| Mar 15, 2021 | 63 | Appendix (Exhibit 1-5B) (30) Docket Text: APPENDIX re [62] Joint Claim Construction Brief by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1-5B)(Mowery, Katharine) |
| Mar 12, 2021 | N/A | Set/Reset Hearings (0) Docket Text: Reset Hearings: The Telephonic Oral Argument is rescheduled per unopposed request of counsel for 3/23/2021 at 10:00 AM before Judge Colm F. Connolly. (nmf) |
| Mar 10, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: A Telephonic Oral Argument re: Defendants' Motion to Dismiss (D.I. [12]) is set for 03/19/2021 at 11:00 a.m. Counsel for Defendants shall coordinate the call and email the dial-in information to chambers. Ordered by Judge Colm F. Connolly on 3/10/2021. (nmf) |
| Mar 10, 2021 | 60 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Sur-Reply Claim Construction Brief filed by Hospira, Inc., Pfizer Inc..(Gattuso, Dominick) |
| Mar 10, 2021 | 61 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Pfizer's First Set of Requests for Production to Amgen (Nos. 1-79) filed by Hospira, Inc., Pfizer Inc..(Gattuso, Dominick) |
| Feb 24, 2021 | 59 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Amgen's Reply Claim Construction Brief and Declaration of Richard C. Willson, Ph.D. in Support of Amgen's Reply Claim Construction Brief filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine) |
| Feb 22, 2021 | 58 | SO ORDERED (2) Docket Text: SO ORDERED, re [57] STIPULATION TO EXTEND TIME for 1) Plaintiffs to serve (but not file) Claim Construction Reply Brief and 2) Defendants to serve (but not file) their Claim Construction Sur-Reply Brief to February 24, 2021 and March 10, 2021 respectively filed by Amgen Inc., Amgen Manufacturing, Limited. Signed by Judge Colm F. Connolly on 2/19/2021. (fms) |
| Feb 19, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney J. Drew Diamond for Amgen Inc., for Amgen Manufacturing, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Feb 18, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [56] MOTION for Pro Hac Vice Appearance of Attorney J Drew Diamond filed by Amgen Inc., Amgen Manufacturing, Limited. Signed by Judge Colm F. Connolly on 2/18/2021. (fms) |
| Feb 17, 2021 | 56 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney J Drew Diamond - filed by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine) |
| Feb 17, 2021 | 57 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for 1) Plaintiffs to serve (but not file) Claim Construction Reply Brief and 2) Defendants to serve (but not file) their Claim Construction Sur-Reply Brief to February 24, 2021 and March 10, 2021 respectively - filed by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine) |
| Feb 5, 2021 | 55 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Pfizer's Answering Claim Construction Brief; and (ii) the Declaration of Todd M. Przybycien, Ph.D. in support of Defendants' Answering Claim Construction Brief filed by Hospira, Inc., Pfizer Inc..(Gattuso, Dominick) |
| Feb 4, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [54] MOTION for Pro Hac Vice Appearance of Attorney Amit H. Thakore of White & Case LLP filed by Hospira, Inc., Pfizer Inc. Signed by Judge Colm F. Connolly on 2/4/2021. (fms) |
| Feb 4, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Amit H. Thakore for Hospira, Inc. and Pfizer Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Feb 3, 2021 | 54 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Amit H. Thakore of White & Case LLP - filed by Hospira, Inc., Pfizer Inc.. (Gattuso, Dominick) |
| Jan 20, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Alison Hanstead, Elizabeth Chang, Brigid Bone, Kevin J. Georgek for Hospira, Inc., and Pfizer Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (sam) |
| Jan 15, 2021 | 53 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Amgen's Opening Claim Construction Brief filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine) |
| Jan 14, 2021 | 52 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Eric Agovino as co-counsel.. (Mowery, Katharine) |
| Jan 4, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [51] MOTION for Pro Hac Vice Appearance of Attorney Dimitrios Drivas, Alison Hanstead, John P. Scheibeler, Kevin J. Georgek, Brigid Bone, and Elizabeth Chang of White & Case LLP filed by Hospira, Inc., Pfizer Inc. Signed by Judge Colm F. Connolly on 1/4/2021. (fms) |
| Jan 4, 2021 | 51 | Motion for Leave to Appear Pro Hac Vice (9) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dimitrios Drivas, Alison Hanstead, John P. Scheibeler, Kevin J. Georgek, Brigid Bone, and Elizabeth Chang of White & Case LLP - filed by Hospira, Inc., Pfizer Inc.. (Gattuso, Dominick) |
| Dec 18, 2020 | 48 | Claim Construction Chart (Main Document) (2) Docket Text: CLAIM Construction Chart by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2 - '707 patent)(Mowery, Katharine) Modified on 12/22/2020 (fms). |
| Dec 18, 2020 | 48 | Claim Construction Chart (Exhibit 1) (6) Docket Text: CLAIM Construction Chart by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2 - '707 patent)(Mowery, Katharine) Modified on 12/22/2020 (fms). |
| Dec 18, 2020 | 48 | Claim Construction Chart (Exhibit 2) (15) Docket Text: CLAIM Construction Chart by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2 - '707 patent)(Mowery, Katharine) Modified on 12/22/2020 (fms). |
| Dec 18, 2020 | 49 | Motion for Miscellaneous Relief (2) Docket Text: MOTION for Claim Construction - filed by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine) |
| Dec 18, 2020 | 50 | Motion for Miscellaneous Relief (2) Docket Text: MOTION for Claim Construction - filed by Hospira, Inc., Pfizer Inc.. (Gattuso, Dominick) |
| Dec 4, 2020 | 46 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Pfizer's Claim Terms for Construction and Proposed Constructions filed by Hospira, Inc., Pfizer Inc..(Gattuso, Dominick) |
| Dec 4, 2020 | 47 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Amgen's Preliminary List of Claim Terms for Construction and Proposed Construction filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine) |
| Nov 16, 2020 | 45 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Pfizer's Responses and Objections to Plaintiffs' First Set of Interrogatories (Nos. 1-9) filed by Hospira, Inc., Pfizer Inc..(Gattuso, Dominick) |
| Oct 27, 2020 | 44 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Defendants Initial Invalidity Contentions [Confidential]; and, (ii) documents bearing bates label PFI00196671 - PFI00197845 filed by Hospira, Inc., Pfizer Inc..(Gattuso, Dominick) |
| Oct 26, 2020 | 43 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Amgen's Objections and Responses to Defendants' First Set of Requests for Admission (Nos. 1-11) and Objections and Responses to First Set of Interrogatories (Nos. 1-7) filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine) |
| Oct 22, 2020 | 42 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Pfizer's Responses and Objections to Plaintiffs' First Set of Requests for Production (Nos. 1-56) filed by Hospira, Inc., Pfizer Inc..(Gattuso, Dominick) |
| Oct 15, 2020 | 41 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of First Set of Interrogatories (Nos. 1-9) filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine) |
| Sep 24, 2020 | 40 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Hospira, Inc. and Pfizer Inc.'s First Set of Interrogatories (Nos. 1-7) and First Set of Requests for Admission (Nos. 1-11) filed by Hospira, Inc., Pfizer Inc..(Gattuso, Dominick) |
| Sep 22, 2020 | 39 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of First Set of Requests for Production (Nos. 1-56) filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine) |
| Sep 11, 2020 | 38 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Amgen's Initial Disclosure of Asserted Claims and Infringement Contentions filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine) |
| Jul 9, 2020 | 37 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Aaron J. Marks as co-counsel.. (Mowery, Katharine) |
| May 12, 2020 | 35 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Amgen's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1); and (2) Amgen's Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery Including Electronically Stored Information filed by Amgen Inc., Amgen Manufacturing, Limited.(Mowery, Katharine) |
| May 12, 2020 | 36 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Defendants Hospira, Inc.s and Pfizer Inc.s Rule 26(a)(1) Disclosures; and (ii) Defendants Hospira, Inc.s and Pfizer Inc.s Disclosures Pursuant to Paragraph 3 of the Default Standard filed by Hospira, Inc., Pfizer Inc..(Gattuso, Dominick) |
| May 7, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [33] SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. ( Joinder of Parties due by 8/20/2021., Amended Pleadings due by 8/20/2021., Discovery due by 11/5/2021., Dispositive Motions due by 4/1/2022., Joint Claim Construction Brief due by 3/15/2021., A Markman Hearing is set for 4/26/2021 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly., Proposed Pretrial Order due by 6/3/2022., A Final Pretrial Conference is set for 6/24/2022 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly., A Jury Trial is set for 7/11/2022 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly.) Signed by Judge Colm F. Connolly on 5/7/2020. (nmf) |
| May 7, 2020 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (cak) |
| May 7, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Counsel are to advise on or before May 28, 2020 by a JOINT EMAIL to Judge Thynge, with a copy to her Judicial Administrator, Ms. Kennedy, their clients interest in mediation and the timing when mediation is preferred with a very brief explanation why. When referencing the timing for mediation, counsel rely on certain events in the scheduling order, for example, before claim construction briefing, after the close of discovery, before expert reports and the like, they are to include the date(s) on when such event(s) occur. Ordered by Chief Magistrate Judge Mary Pat Thynge on 5/7/20. (cak) |
| May 4, 2020 | 33 | Proposed Order (Main Document) (25) Docket Text: PROPOSED ORDER for Patent Cases in Which Infringement is Alleged by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit A, # (2) Letter)(Mowery, Katharine) |
| May 4, 2020 | 33 | Proposed Order (Exhibit A) (2) Docket Text: PROPOSED ORDER for Patent Cases in Which Infringement is Alleged by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit A, # (2) Letter)(Mowery, Katharine) |
| May 4, 2020 | 33 | Proposed Order (Letter) (1) Docket Text: PROPOSED ORDER for Patent Cases in Which Infringement is Alleged by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit A, # (2) Letter)(Mowery, Katharine) |
| Apr 22, 2020 | 32 | Redacted Document (15) Docket Text: REDACTED VERSION of [30] Reply Brief Defendants' Reply Brief in Support of Motion to Dismiss by Hospira, Inc., Pfizer Inc.. (Gattuso, Dominick) |
| Apr 15, 2020 | 31 | Request for Oral Argument (2) Docket Text: REQUEST for Oral Argument by Hospira, Inc., Pfizer Inc. re [12] MOTION to Dismiss for Failure to State a Claim . (Gattuso, Dominick) |
| Apr 13, 2020 | 28 | Redacted Document (30) Docket Text: REDACTED VERSION of [24] Answering Brief in Opposition, by Amgen Inc., Amgen Manufacturing, Limited. (Whetzel, Robert) |
| Apr 13, 2020 | 29 | Redacted Document (30) Docket Text: REDACTED VERSION of [26] Exhibit to a Document by Amgen Inc., Amgen Manufacturing, Limited. (Whetzel, Robert) |
| Apr 9, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [27] STIPULATION TO EXTEND TIME for Amgen to file redacted versions of the Sealed Filings to April 13, 2020 filed by Hospira, Inc., Pfizer Inc. Ordered by Judge Colm F. Connolly on 4/9/2020. (fms) |
| Apr 8, 2020 | 27 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for Amgen to file redacted versions of the Sealed Filings to April 13, 2020 - filed by Hospira, Inc., Pfizer Inc.. (Gattuso, Dominick) |
| Apr 1, 2020 | 25 | Declaration (Main Document) (3) Docket Text: DECLARATION re [24] Answering Brief in Opposition, [Declaration of Jennifer H. Wu] by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit I-M, # (2) Exhibit N)(Whetzel, Robert) |
| Apr 1, 2020 | 25 | Declaration (Exhibit I-M) (30) Docket Text: DECLARATION re [24] Answering Brief in Opposition, [Declaration of Jennifer H. Wu] by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit I-M, # (2) Exhibit N)(Whetzel, Robert) |
| Apr 1, 2020 | 25 | Declaration (Exhibit N) (30) Docket Text: DECLARATION re [24] Answering Brief in Opposition, [Declaration of Jennifer H. Wu] by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibit I-M, # (2) Exhibit N)(Whetzel, Robert) |
| Mar 13, 2020 | 22 | Proposed Order (26) Docket Text: PROPOSED ORDER Entry of a Protective Order regarding discovery by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine) |
| Mar 13, 2020 | 23 | Protective Order (26) Docket Text: PROTECTIVE ORDER Signed by Judge Colm F. Connolly on 3/13/2020. (nmf) |
| Mar 11, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [21] STIPULATION TO EXTEND TIME for Plaintiffs to file their Brief in Opposition to Motion to Dismiss to April 1, 2020; Defendants' Reply Deadline is extended by one week filed by Amgen Inc., Amgen Manufacturing, Limited, Set Briefing Schedule: re [12] MOTION to Dismiss for Failure to State a Claim . (Answering Brief due 4/1/2020.). Signed by Judge Colm F. Connolly on 3/11/2020. (fms) |
| Mar 11, 2020 | 19 | Redacted Document (Main Document) (26) Docket Text: REDACTED VERSION of [16] Opening Brief in Support, of Motion to Dismiss by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit Certificate of Service)(Gattuso, Dominick) |
| Mar 11, 2020 | 19 | Redacted Document (Exhibit Certificate of Service) (1) Docket Text: REDACTED VERSION of [16] Opening Brief in Support, of Motion to Dismiss by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit Certificate of Service)(Gattuso, Dominick) |
| Mar 11, 2020 | 20 | Redacted Document (Main Document) (2) Docket Text: REDACTED VERSION of [13] Declaration, of Claire A. Fundakowski In Support of Defendants Motion to Dismiss by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C - Shall Remain Under Seal In Its Entirety, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G- Shall Remain Under Seal In Its Entirety, # (8) Exhibit Certificate of Service)(Gattuso, Dominick) |
| Mar 11, 2020 | 20 | Redacted Document (Exhibit A) (20) Docket Text: REDACTED VERSION of [13] Declaration, of Claire A. Fundakowski In Support of Defendants Motion to Dismiss by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C - Shall Remain Under Seal In Its Entirety, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G- Shall Remain Under Seal In Its Entirety, # (8) Exhibit Certificate of Service)(Gattuso, Dominick) |
| Mar 11, 2020 | 20 | Redacted Document (Exhibit B) (15) Docket Text: REDACTED VERSION of [13] Declaration, of Claire A. Fundakowski In Support of Defendants Motion to Dismiss by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C - Shall Remain Under Seal In Its Entirety, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G- Shall Remain Under Seal In Its Entirety, # (8) Exhibit Certificate of Service)(Gattuso, Dominick) |
| Mar 11, 2020 | 20 | Redacted Document (Exhibit C - Shall Remain Under Seal In Its Entirety) (1) Docket Text: REDACTED VERSION of [13] Declaration, of Claire A. Fundakowski In Support of Defendants Motion to Dismiss by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C - Shall Remain Under Seal In Its Entirety, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G- Shall Remain Under Seal In Its Entirety, # (8) Exhibit Certificate of Service)(Gattuso, Dominick) |
| Mar 11, 2020 | 20 | Redacted Document (Exhibit D) (30) Docket Text: REDACTED VERSION of [13] Declaration, of Claire A. Fundakowski In Support of Defendants Motion to Dismiss by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C - Shall Remain Under Seal In Its Entirety, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G- Shall Remain Under Seal In Its Entirety, # (8) Exhibit Certificate of Service)(Gattuso, Dominick) |
| Mar 11, 2020 | 20 | Redacted Document (Exhibit E) (16) Docket Text: REDACTED VERSION of [13] Declaration, of Claire A. Fundakowski In Support of Defendants Motion to Dismiss by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C - Shall Remain Under Seal In Its Entirety, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G- Shall Remain Under Seal In Its Entirety, # (8) Exhibit Certificate of Service)(Gattuso, Dominick) |
| Mar 11, 2020 | 20 | Redacted Document (Exhibit F) (30) Docket Text: REDACTED VERSION of [13] Declaration, of Claire A. Fundakowski In Support of Defendants Motion to Dismiss by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C - Shall Remain Under Seal In Its Entirety, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G- Shall Remain Under Seal In Its Entirety, # (8) Exhibit Certificate of Service)(Gattuso, Dominick) |
| Mar 11, 2020 | 20 | Redacted Document (Exhibit G- Shall Remain Under Seal In Its Entirety) (1) Docket Text: REDACTED VERSION of [13] Declaration, of Claire A. Fundakowski In Support of Defendants Motion to Dismiss by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C - Shall Remain Under Seal In Its Entirety, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G- Shall Remain Under Seal In Its Entirety, # (8) Exhibit Certificate of Service)(Gattuso, Dominick) |
| Mar 11, 2020 | 20 | Redacted Document (Exhibit Certificate of Service) (1) Docket Text: REDACTED VERSION of [13] Declaration, of Claire A. Fundakowski In Support of Defendants Motion to Dismiss by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C - Shall Remain Under Seal In Its Entirety, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G- Shall Remain Under Seal In Its Entirety, # (8) Exhibit Certificate of Service)(Gattuso, Dominick) |
| Mar 11, 2020 | 21 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Plaintiffs to file their Brief in Opposition to Motion to Dismiss to April 1, 2020; Defendants' Reply Deadline is extended by one week - filed by Amgen Inc., Amgen Manufacturing, Limited. (Mowery, Katharine) |
| Mar 9, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Naz Erdeniz Wehrli for Amgen Inc. and Amgen Manufacturing, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Mar 6, 2020 | 18 | Order on Motion to Seal Document (1) Docket Text: ORDER granting [11] Motion to Seal Document. Signed by Judge Colm F. Connolly on 3/6/2020. (fms) |
| Mar 5, 2020 | N/A | Deficiency Notice (0) Docket Text: DEFICIENCY NOTICE by the Court issued to Dominick Gattuso, Esq. re [11] Motion to Seal Document. Please see L.R. RULE 7.1.1. Statement Required to be Filed with Nondispositive Motions. The motion lacks this statement. (fms) |
| Mar 5, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Nicholas Groombridge for Amgen Inc.,Nicholas Groombridge for Amgen Manufacturing, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Mar 5, 2020 | 17 | Statement (2) Docket Text: STATEMENT re [11] MOTION to Seal Document: Motion for Leave to File Defendants' Opening Brief In Support of Motion to Dismiss and Declaration of Claire A. Fundakowski Under Seal Rule 7.1.1 Certification by Hospira, Inc., Pfizer Inc.. (Gattuso, Dominick) |
| Mar 4, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Paula S. Fritsch for Amgen Inc. and Amgen Manufacturing, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Mar 4, 2020 | 11 | Motion to Seal Document (Main Document) (4) Docket Text: MOTION to Seal Document: Motion for Leave to File Defendants' Opening Brief In Support of Motion to Dismiss and Declaration of Claire A. Fundakowski Under Seal - filed by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Text of Proposed Order [Proposed] Order)(Gattuso, Dominick) |
| Mar 4, 2020 | 11 | Motion to Seal Document (Text of Proposed Order [Proposed] Order) (1) Docket Text: MOTION to Seal Document: Motion for Leave to File Defendants' Opening Brief In Support of Motion to Dismiss and Declaration of Claire A. Fundakowski Under Seal - filed by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Text of Proposed Order [Proposed] Order)(Gattuso, Dominick) |
| Mar 4, 2020 | 12 | Motion to Dismiss for Failure to State a Claim (Main Document) (2) Docket Text: MOTION to Dismiss for Failure to State a Claim - filed by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Text of Proposed Order [Proposed] Order)(Gattuso, Dominick) |
| Mar 4, 2020 | 12 | Motion to Dismiss for Failure to State a Claim (Text of Proposed Order [Proposed] Order) (1) Docket Text: MOTION to Dismiss for Failure to State a Claim - filed by Hospira, Inc., Pfizer Inc.. (Attachments: # (1) Text of Proposed Order [Proposed] Order)(Gattuso, Dominick) |
| Mar 4, 2020 | 14 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Hospira, Inc.. (Gattuso, Dominick) |
| Mar 4, 2020 | 15 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Pfizer Inc.. (Gattuso, Dominick) |
| Mar 3, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jennifer H. Wu for Amgen Inc.,for Amgen Manufacturing, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Mar 3, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Peter Sandel for Amgen Inc., for Amgen Manufacturing, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Mar 3, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jennifer Gordon for Amgen Inc.,for Amgen Manufacturing, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Mar 3, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Aaron J. Marks for Amgen Inc.,for Amgen Manufacturing, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Mar 3, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jacob T. Whitt for Amgen Inc.,for Amgen Manufacturing, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Mar 3, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kimberlin L. Morley for Amgen Inc.,for Amgen Manufacturing, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Mar 2, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] MOTION for Pro Hac Vice Appearance of Attorney Wendy A. Whiteford, Kimberlin L. Morley, Eric Agovino and Paula Fritsch of Amgen, Inc. filed by Amgen Inc., Amgen Manufacturing, Limited, [10] MOTION for Pro Hac Vice Appearance of Attorney Jennifer H. Wu, Nicholas Groombridge, Jennifer Gordon, Peter Sandel, Naz E. Wehrli, Jacob T. Whitt, and Aaron J. Marks of Paul, Weiss, Rifkind, Wharton & Garrison LLP filed by Amgen Inc., Amgen Manufacturing, Limited. Signed by Judge Colm F. Connolly on 3/2/2020. (fms) |
| Mar 2, 2020 | 9 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Wendy A. Whiteford, Kimberlin L. Morley, Eric Agovino and Paula Fritsch of Amgen, Inc. - filed by Amgen Inc., Amgen Manufacturing, Limited. (Whetzel, Robert) |
| Mar 2, 2020 | 10 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jennifer H. Wu, Nicholas Groombridge, Jennifer Gordon, Peter Sandel, Naz E. Wehrli, Jacob T. Whitt, and Aaron J. Marks of Paul, Weiss, Rifkind, Wharton & Garrison LLP - filed by Amgen Inc., Amgen Manufacturing, Limited. (Whetzel, Robert) |
| Feb 28, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Claire A. Fundakowski for Hospira, Inc. and Pfizer Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Feb 21, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Alison M. Heydorn for Hospira, Inc. and Pfizer Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Feb 20, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Charles B. Klein for Hospira, Inc. and for Pfizer Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d), Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (sam) |
| Feb 19, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Feb 19, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Jovial Wong, Claire A. Fundakowski, and Alison M. Heydorn filed by Hospira, Inc., Pfizer Inc. Signed by Judge Colm F. Connolly on 2/19/2019. (fms) |
| Feb 19, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jovial Wong for Hospira, Inc. and Pfizer Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Feb 19, 2020 | 8 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Jovial Wong, Claire A. Fundakowski, and Alison M. Heydorn - filed by Hospira, Inc., Pfizer Inc.. (Gattuso, Dominick) |
| Feb 13, 2020 | 5 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Amgen Inc., Amgen Manufacturing, Limited. Hospira, Inc. served on 2/12/2020, answer due 3/4/2020. (Mowery, Katharine) |
| Feb 13, 2020 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Amgen Inc., Amgen Manufacturing, Limited. Pfizer Inc. served on 2/12/2020, answer due 3/4/2020. (Mowery, Katharine) |
| Feb 13, 2020 | 7 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Dominick T. Gattuso on behalf of Hospira, Inc., Pfizer Inc. (Gattuso, Dominick) |
| Feb 11, 2020 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Hospira, Inc. on 2/11/2020; Pfizer Inc. on 2/11/2020. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (kmd) |
| Feb 11, 2020 | 1 | Complaint (Main Document) (16) Docket Text: COMPLAINT filed with Jury Demand against Hospira, Inc., Pfizer Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2850056.) - filed by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibits 1-3, # (2) Civil Cover Sheet)(kmd) |
| Feb 11, 2020 | 1 | Complaint (Exhibit 1-3) (30) Docket Text: COMPLAINT filed with Jury Demand against Hospira, Inc., Pfizer Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2850056.) - filed by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibits 1-3, # (2) Civil Cover Sheet)(kmd) |
| Feb 11, 2020 | 1 | Complaint (Civil Cover Sheet) (1) Docket Text: COMPLAINT filed with Jury Demand against Hospira, Inc., Pfizer Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2850056.) - filed by Amgen Inc., Amgen Manufacturing, Limited. (Attachments: # (1) Exhibits 1-3, # (2) Civil Cover Sheet)(kmd) |
| Feb 11, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd) |
| Feb 11, 2020 | 3 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,273,707. (kmd) |
| Feb 11, 2020 | 4 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amgen Inc. for Amgen Manufacturing, Limited - filed by Amgen Inc., Amgen Manufacturing, Limited. (kmd) |
| Feb 11, 2020 | 1 | Complaint* (1) |
